Indeed, IL1RAP knockdown in primary AML cells is accompanied by a reduction in clonogenicity, and BM cells from IL1RAP knockout (IL1RAP-/-) mice transduced with MLL-AF9 fusion viruses show slower disease progression than recipients of wild type cells transduced with the same onco-vector [54]. The gene discussed is IL1RAP; the disease is acute myeloid leukemia.